In this white paper, Crown Bioscience aims to improve the customer's understanding of the strengths, limitations, and differences across the range of available IBD models, which will help overcome the challenges associated with selecting and implementing the best translational model possible.
Editorial Article: Personalized medicine: Emerging organoid models to better treat prostate cancer
Dr. Veronica Gil discusses how 3D cell culture is enabling scientists to develop and craft organ-specific tissues from stem cells to transform prostate cancer therapy
16 Apr 2021
Dr. Veronica Gil, Higher Scientific Officer at the Institute of Cancer Research in London
In this exclusive interview, we learn about Dr. Veronica Gil’s work on the development and establishment of in vivo and 3D
in vitro models to improve understanding of the mechanisms underlying advanced prostate cancer. Gil is a Higher Scientific Officer at the Institute of Cancer Research in London, where she works as part of the Cancer Biomarkers team led by Prof. Johann de Bono.